CELC Celcuity Inc

Price (delayed)

$92.66

Market cap

$4.52B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$3.91

Enterprise value

$4.7B

Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 3

Celcuity is a clinical stage biotechnology company translating discoveries of new cancer sub-types into pioneering companion diagnostics and expanded therapeutic options for cancer patients. Celcuity's 3rd generation diagnostic platform, CELsignia, ...

Highlights
The quick ratio has surged by 86% year-on-year and by 17% since the previous quarter
CELC's net income has plunged by 52% YoY and by 9% from the previous quarter
The equity has contracted by 47% from the previous quarter and by 38% YoY

Key stats

What are the main financial stats of CELC

CELC stock price

How has the Celcuity stock price performed over time
Intraday
4.17%
1 week
-29.22%
1 month
-36.09%
1 year
673.46%
YTD
-7.1%
QTD
-18.82%

Financial performance

How have Celcuity's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$186.57M
Net income
-$192.89M
Gross margin
N/A
Net margin
N/A
CELC's net income has plunged by 52% YoY and by 9% from the previous quarter
The operating income has declined by 47% year-on-year and by 8% since the previous quarter

Price vs fundamentals

How does CELC's price correlate with its fundamentals

Growth

What is Celcuity's growth rate over time

Valuation

What is Celcuity stock price valuation
P/E
N/A
P/B
83.68
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The company's EPS fell by 28% YoY and by 3.2% QoQ
CELC's price to book (P/B) is 80% more than its last 4 quarters average of 44.6
The equity has contracted by 47% from the previous quarter and by 38% YoY

Efficiency

How efficient is Celcuity business performance
The ROE has plunged by 154% YoY and by 20% from the previous quarter
Celcuity's return on invested capital has increased by 9% YoY and by 8% QoQ
The return on assets has increased by 4.7% since the previous quarter

Dividends

What is CELC's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for CELC.

Financial health

How did Celcuity financials performed over time
Celcuity's total assets is 15% more than its total liabilities
CELC's total liabilities has surged by 171% year-on-year but it is down by 2.6% since the previous quarter
Celcuity's total assets has soared by 88% YoY but it has decreased by 12% from the previous quarter
The company's debt to equity has surged by 89% QoQ
The equity has contracted by 47% from the previous quarter and by 38% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.